{
    "Trade/Device Name(s)": [
        "Healgen COC One Step Cocaine Test (Strip, Cassette, Cup, Dip Card)",
        "Healgen MOP One Step Morphine Test (Strip, Cassette, Cup, Dip Card)"
    ],
    "Submitter Information": "HEALGEN SCIENTIFIC LLC",
    "510(k) Number": "K141647",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052115"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIO",
        "DJG"
    ],
    "Summary Letter Date": "July 17, 2014",
    "Summary Letter Received Date": "June 19, 2014",
    "Submission Date": "June 16, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.3250",
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Cocaine and cocaine metabolite test system",
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Benzoylecgonine",
        "Morphine"
    ],
    "Specimen Type(s)": [
        "Human Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunochromatographic assay"
    ],
    "Submission Type(s)": [
        "Strip",
        "Cassette",
        "Cup",
        "Dip Card"
    ],
    "Document Summary": "FDA 510(k) summary for Healgen COC One Step Cocaine Test and Healgen MOP One Step Morphine Test for qualitative detection of benzoylecgonine and morphine in human urine using lateral flow immunochromatographic assay formats",
    "Indications for Use Summary": "Immunochromatographic assays for qualitative detection of benzoylecgonine or morphine in human urine at 300 ng/mL cut-off; for over-the-counter and prescription use as preliminary drug of abuse screening",
    "fda_folder": "Toxicology"
}